Search results
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
FOX 23 News Albany· 2 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter 2024 financial ...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 1 week agoThe R21/Matrix-M vaccine, developed by Oxford University and the Serum Institute of India,...